PT - JOURNAL ARTICLE AU - Stephen F. Fitzgerald AU - Gianluigi Rossi AU - Alison S. Low AU - Sean P. McAteer AU - Brian O’Keefe AU - David Findlay AU - Graeme J. Cameron AU - Peter Pollard AU - Peter T. R. Singleton AU - George Ponton AU - Andrew C. Singer AU - Kata Farkas AU - Davey Jones AU - David W Graham AU - Marcos Quintela-Baluja AU - Christine Tait-Burkard AU - David L. Gally AU - Rowland Kao AU - Alexander Corbishley TI - COVID-19 mass testing: harnessing the power of wastewater epidemiology AID - 10.1101/2021.05.24.21257703 DP - 2021 Jan 01 TA - medRxiv PG - 2021.05.24.21257703 4099 - http://medrxiv.org/content/early/2021/05/26/2021.05.24.21257703.short 4100 - http://medrxiv.org/content/early/2021/05/26/2021.05.24.21257703.full AB - Background COVID-19 patients shed SARS-CoV-2 RNA in their faeces. We hypothesised that detection of SARS-CoV-2 RNA in wastewater treatment plant (WWTP) influent could be a valuable tool to assist in public health decision making. We aimed to rapidly develop and validate a scalable methodology for the detection of SARS-CoV-2 RNA in wastewater that could be implemented at a national level and to determine the relationship between the wastewater signal and COVID-19 cases in the community.Methods We developed a filtration-based methodology for the concentration of SARS-CoV-2 from WWTP influent and subsequent detection and quantification by RT-qPCR. This methodology was used to monitor 28 WWTPs across Scotland, serving 50% of the population. For each WWTP catchment area, we collected data describing COVID-19 cases and deaths. We quantified spatial and temporal relationships between SARS-CoV-2 RNA in wastewater and COVID-19 cases.Findings Daily WWTP SARS-CoV-2 influent viral RNA load, calculated using daily influent flow rates, had the strongest correlation (ρ>0.9) with COVID-19 cases within a catchment. As the incidence of COVID-19 cases within a community increased, a linear relationship emerged between cases and influent viral RNA load. There were significant differences between WWTPs in their capacity to predict case numbers based on influent viral RNA load, with the limit of detection ranging from twenty-five cases for larger plants to a single case in smaller plants.Interpretation The levels of SARS-CoV-2 RNA in WWTP influent provide a cost-effective and unbiased measure of COVID-19 incidence within a community, indicating that national scale wastewater-based epidemiology can play a role in COVID-19 surveillance. In Scotland, wastewater testing has been expanded to cover 75% of the population, with sub-catchment sampling being used to focus surge testing. SARS-CoV-2 variant detection, assessment of vaccination on community transmission and surveillance for other infectious diseases represent promising future applications.Funding This study was funded by project grants from the Scottish Government via the Centre of Expertise for Waters (CD2019/06) and The Natural Environment Research Council’s COVID-19 Rapid Response grants (NE/V010441/1). The Roslin Institute receives strategic funding from the Biotechnology and Biological Sciences Research Council (BB/P013740/1, BBS/E/D/20002173). Sample collection and supplementary analysis was funded and undertaken by Scottish Water and the majority of the sample analysis was funded and undertaken by the Scottish Environment Protection Agency.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by project grants from the Scottish Government via the Centre of Expertise for Waters (CD2019/06) and The Natural Environment Research Council's COVID19 Rapid Response grants (NE/V010441/1). The Roslin Institute receives strategic funding from the Biotechnology and Biological Sciences Research Council (BB/P013740/1, BBS/E/D/20002173). Sample collection and supplementary analysis was funded and undertaken by Scottish Water and the majority of the sample analysis was funded and undertaken by the Scottish Environment Protection Agency.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Sharing of aggregated patient data at the datazone level (see material and methods) was approved by the Public Benefit and Privacy Panel for Health and Social Care (NHS Scotland), reference 2021–0193. No other ethical approval was required for this observational study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll scripts and models used in this study will be made available upon request to the corresponding authors. Wastewater SARS–CoV–2 RNA levels are publicly available from SEPA here: https://informatics.sepa.org.uk/RNAmonitoring/. The authors cannot share the wastewater treatment plant catchment areas and patient data aggregated at the datazone level, which are subject to data sharing agreements and must be requested directly from Scottish Water and Public Health Scotland respectively.